Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants

JAMA

Volumn 275, Issue 7, 1996, Pages 539-544

  Varvarigou, Anastasia ^a,c   Bardin, Claudette L ^a   Beharry, Kay ^a   Chemtob, Sylvain ^b   Papageorgiou, Apostolos ^a   Aranda, Jacob V ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; IBUPROFEN LYSINE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEWBORN; NEWBORN INTENSIVE CARE; PATENT DUCTUS ARTERIOSUS; PHASE 1 CLINICAL TRIAL; PREMATURITY; PRIORITY JOURNAL;

EID: 0030027438     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.7.539     Document Type: Article

References (36)

1. Clyman RI. Medical treatment of patent ductus arteriosus in premature infants. In: Long WA, ed. Fetal and Neonatal Cardiology. Philadelphia, Pa: WB Saunders; 1990:682-690.
2. Cotton RB, Stahlman MT, Kovar I, Catterton WZ. Medical management of small preterm infants with symptomatic patent ductus arteriosus. J Pediatr. 1979;2:467-473.
3. Cotton RB, Stahlman MT, Bender HW, Graham TP, Catterton WZ, Kovar I. Randomized trial of early closure of symptomatic patent duetus arteriosus in small preterm infants. J Pediatr. 1978;93: 647-651.
4. Naulty CM, Horn S, Corny J, Avery GB. Improved lung compliance after ligation of patent ductus arteriosus in hyaline membrane disease. J Pediatr. 1978;93:682-684.
5. Mahony L, Carnero V, Brett C, Heymann MA, Clyman RI. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. N Engl J Med. 1982;306:506-510.
6. Yeh TF, Luken JA, Thaliji A, Raval D, Carr I, Pildes RS. Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus: a double-blind controlled study. J Pediatr. 1981; 98:137-145.
7. Merritt TA, Harris JP, Roghmann K, et al. Early closure of the patent ductus arteriosus in very low birth weight infants: a controlled trial. J Pediatr. 1981;99:281-286.
8. Gersony WM, Peekham GJ, Ellison CR, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr. 1983;102:895-906.
9. Cotton RB, Haywood JL, Fitzgerald GA. Symptomatic patent ductus arteriosus following prophylactic indomethacin. Biol Neonate. 1991;60:273-282.
10. Rennie JM, Doyle J, Cooke RWI. Early administration of indomethacin to preterm infants. Arch Dis Child. 1986;61:233-238.
11. Krueger E, Mellander M, Bratton D, Cotton R. Prevention of symptomatic patent ductus arteriosus with a single dose of indomethacin. J Pediatr. 1987;111:749-754.
12. Bada HS, Green RS, Pourcyrous ML, et al. Indomethacin reduces the risk of severe intraventricular hemorrhage. J Pediatr. 1989;115:631-637.
13. Ment LR, Oh W, Ehrenkranz RA, et al. Low dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics. 1994;93:543-550.
14. Betkerur MV, Yeh TF, Miller K, Glasser EJ, Pildes RS. Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus. Pediatrics. 1981;8:99-102.
15. Van Bel F, Guit GL, Schipper J, van de Bor M, Baan J. Indomethacin-induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging. J Pediatr. 1991;118:621-626.
16. Leffler CW, Busija DW. Prostanoids and pial arteriolar diameter in hypotensive newborn pigs. Am J Physiol. 1987;252:H687-H691.
17. Laudignon N, Chemtob S, Bard H, Aranda JV. Effect of indomethacin on the cerebral blood flow velocity of premature newborns. Biol Neonate. 1988; 54:254-262.
18. Coceani F, White E, Bodach E, Olley PM. Age-dependent changes in the response of the lamb ductus arteriosus to oxygen and ibuprofen. Can J Physiol Pharmacol. 1979;57:825-831.
19. Chemtob S, Laudignon N, Beharry K, et al. Effects of prostaglandins and indomethacin on cerebral blood flow and oxygen consumption of conscious newborn piglets. Dev Pharmacol Ther. 1990; 14:1-14.
20. Chemtob S, Beharry K, Rex J, Varma DR, Aranda JV. Prostanoids determine the range of cerebral blood flow autoregulation of newborn piglets. Stroke. 1990;1:777-784.
21. Chemtob S, Beharry K, Barna T, Varma DR, Aranda JV. Differences in the effects in the newborn piglet of various nonsteroidal antiinflammatory drugs on cerebral blood flow but not on cerebrovascular prostaglandins. Pediatr Res. 1991;30: 106-111.
22. Malcolm DD, Segar JL, Robillard E, Chemtob S. Indomethacin compromises hemodynamics during positive-pressure ventilation, independently of prostanoids. J Appl Physiol. 1993;74:1672-1678.
23. Chemtob S, Roy M-S, Abran D, Fernandez H, Varma DR. Prevention of post-asphyxial increase in lipid peroxides and retinal function deterioration in the newborn pig by inhibition of cyclooxygenase activity and free radical generation. Pediatr Res. 1993;33:336-340.
24. Kauffman RE, Nelson MV. Effect of age on ibuprofen pharmacokineties and antipyretic response. J Pediatr. 1992;121:969-973.
25. Aranda JV, Varvarigou N, Beharry K, et al. Pharmacokinetics of intravenous ibuprofen in premature newborns. Pediatr Res. 1994;35:81A. Abstract.
26. Aravind MK, Miceli JN, Kauffman RE. Determination of ibuprofen by high-performance liquid chromatography. J Chromatography. 1984;308:350-353.
27. Papile LA, Burstein J, Burstein R, Keffler H. Incidence and evolution of sabependymal and intraventrieular hemorrhage: a study of infants with birth weights less than 1500 grams. J Pediatr. 1978; 92:529-534.
28. Ortiz EM, Cilley RE, Bartlett RH. Extracorporeal membrane oxygenation in pediatric respiratory failure. Pediatr Clin North Am. 1987;34: 39-46.
29. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirements in the neonatal period. Pediatrics. 1988;82: 527-532.
30. The Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol. 1984;102:1130-1134.
31. Sokal RR, Rohlf FJ, eds. Biometry. 2nd ed. New York, NY: WH Freeman & Co; 1981:232-241.
32. Ferguson GA, ed. Statistical Analysis in Psychology and Education. 3rd ed. New York, NY: McGraw Hill Inc; 1971:276-287.
33. Gallo JM, Gall IP, Gillespie WR, Albert KS, Perrier D. Ibuprofen kinetics in plasma and synovial fluid of arthritic patients. J Clin Pharmacol. 1986;6:65-70.
34. Brothwood M, Wolke D, Gamsu H, Benson J, Cooper D. Prognosis of the very low birthweight baby in relation to gender. Arch Dis Child. 1986; 61:559-564.
35. Perlman JM, Goodman S, Kreusser KL, et al. Reduction in intraventricular hemorrhage by elimination of fluctuating cerebral blood flow velocity in preterm infants with respiratory distress syndrome. N Engl J Med. 1985;312:1353-1357.
36. Bandstra ES, Montalvo BM, Goldberg RN, et al. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Pediatrics. 1988;82:533-542.